S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis)

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Lavelle, Donald ^a,b   Saunthararajah, Yogen ^a,c   Vaitkus, Kestis ^a,b   Singh, Mahipal ^a,b,e   Banzon, Virryan ^a,b   Phiasivongsva, Pasit ^d   Redkar, Sanjeev ^d   Kanekal, Sarath ^d   Bearss, David ^d   Shi, Chongtie ^d   Inloes, Roger ^d   DeSimone, Joseph ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d SuperGen Inc   (United States)

^e FORT VALLEY STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CYTIDINE; GAMMA GLOBIN; HEMOGLOBIN F; NUCLEOSIDE DERIVATIVE; S 110; UNCLASSIFIED DRUG; DRUG DERIVATIVE; OLIGONUCLEOTIDE; S110 COMPOUND;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BABOON; CONTROLLED STUDY; DNA BINDING; DNA METHYLATION; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG STRUCTURE; ERYTHROID PRECURSOR CELL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PROMOTER REGION; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; GENETICS; METABOLISM;

ANIMALS; AZACITIDINE; DNA METHYLATION; FETAL HEMOGLOBIN; OLIGONUCLEOTIDES; PAPIO; PROMOTER REGIONS, GENETIC;

EID: 77957571596     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-92     Document Type: Article

References (21)

1. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991, 325:11-16. 10.1056/NEJM199107043250103, 1710777.
2. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994, 330:1639-1644. 10.1056/NEJM199406093302303, 7993409.
3. Koshy M, Dorn L, Bressler L, Molokie R, Lavelle D, Talischy N, Hoffman R, van Overveld W, DeSimone J. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia. Blood 2000, 96:2379-384.
4. DeSimone J, Koshy M, Dorn L, Lavelle D, Bressler L, Molokie R, Talischy N. Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia. Blood 2000, 99:3905-3908.
5. Saunthararajah Y, Hillery CA, Lavelle D, Molokie R, Dorn L, Bressler L, Gavasova S, Chen YH, Hoffman R, DeSimone J. Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. Blood 2000, 102:3865-3870.
6. Saunthararajah Y, Lavelle D, DeSimone J. DNA hypomethylating agents and sickle cell disease. Br J Hematol 2004, 126:629-636.
7. Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J. Clinical effectiveness of decitabine in severe sickle cell disease. Br J Hematol 2008, 141:126-129.
8. DeSimone J, Heller P, Molokie R, Hall L, Zwiers D. Tetrahydrouridine, cytidine analogues, and hemoglobin F. Am J Hematol 1985, 18:283-288. 10.1002/ajh.2830180310, 2579548.
9. Lavelle D, Chin J, Vaitkus K, Redkar S, Phiasivongsva P, Tang C, Will R, Hankewych M, Roxas B, Singh M, Saunthararajah Y, DeSimone J. Oral decitabine reactivates expression of the methylated gamma-globin gene in Papio anubis. Am J Hematol 2007, 82:981-985. 10.1002/ajh.21020, 17696208.
10. Yoo CB, Jeong S, Egger G, Liang G, Phiasivongsva P, Tang C, Redkar S, Jones PA. Delivery of 5-aza-2'-deoxycytidine to cells using oligodeoxynucleotides. Cancer Res 2007, 67:6400-6408. 10.1158/0008-5472.CAN-07-0251, 17616700.
11. Migliaccio G, Di Pietro R, di Giacomo V, Di Baldassarre A, Migliaccio AR, Maccioni L, Galanello R, Papayannopoulou T. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis 2002, 28:169-180. 10.1006/bcmd.2002.0502, 12064913.
12. Singer K, Chernoff AL, Singer L. Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation. Blood 1951, 6:413-428.
13. Leone L, Monteleone M. Reversed-phase high-performance liquid chromatography of human hemoglobin chains. J Chromatog 1985, 321:407-419.
14. Raizis AM, Schmitt F, Jost J-P. A bisulfite method of 5-methylcytosine mapping that minimizes template degradation. Anal Biochem 1995, 226:161-166. 10.1006/abio.1995.1204, 7785768.
15. Lavelle D, Vaitkus K, Hankewych M, Singh M, DeSimone J. The effect of 5-aza-2'-deoxycytidine (Decitabine) on covalent histone modifications of chromatin associated with the ε-, γ-, and β-globin genes in baboon (P. anubis). Exp Hematol 2006, 34:339-347. 10.1016/j.exphem.2005.12.010, 16543068.
16. Cashen AF, Shah AK, Todt L, Fisher N, DiPersio J. Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome. Cancer Chemother Pharmacol 2008, 61:759-766. 10.1007/s00280-007-0531-7, 17564707.
17. Mabraera R, Greene MR, Richardson CA, Conine SJ, Kozul CD, Lowrey CH. Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin. Blood 2007, 111:411-420. 10.1182/blood-2007-06-093948, 2200821, 17916742.
18. Lavelle D, Saunthararajah Y, DeSimone J. DNA methylation and the mechanism of action of 5-azacytidine. Blood 2008, 111:2485. 10.1182/blood-2007-10-119867, 18263785.
19. Ibanez V, Banzon V, Kousnetzova T, Vaitkus K, Peterson K, DeSimone J, Lavelle D. The role of DNA damage/stress response pathways in the mechanism of action of decitabine. Blood 2008, 112:490A.
20. Sangerman J, Lee MS, Yao X, Oteng E, Hsiao CH, Li W, Zein S, Ofori-Acquah SF, Pace BS. Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2. Blood 2006, 108:3590-3599. 10.1182/blood-2006-01-023713, 1895433, 16896160.
21. Papayannopoulou T, Brice M, Stamatoyannopouolos G. Hemoglobin F synthesis in vitro: evidence for control at the level of proimitive erythroid stem cells. Proc Natl Acad Sci USA 1977, 74:2923-2927. 10.1073/pnas.74.7.2923, 431348, 268643.